RNASE3 and asthma: Among the 402 MPP patients with allergic conditions, the 12 patients (3.0%) who developed secondary asthma had ECP and IgE levels of (24.31 ± 2.12) μg/L and (245.25 ± 20.1) IU/mL, respectively.